RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
146 hedge funds and large institutions have $841M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 45 increasing their positions, 45 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
-3
Holders Change %
-2.01%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
45
Reduced
45
Closed
15
Calls
$13.2M
Puts
$8.04M
Net Calls
+$5.14M
Net Calls Change
+$53.9M
